Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00640042 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Risk Minimization, Assessment and Outcomes in Patients With Chronic Pain Taking Avinza
A Phase 4 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,570
- Enrollment target
NCT00640042: Completed Phase 4 study, sponsored by Pfizer.
NCT00640042 is a Phase 4 study that has completed, run by Pfizer. The registered enrollment target is 1,570 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (203% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00640042, a Phase 4 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,570 participants
- Enrollment target
Study Summary
The purpose of this study is to provide information in a broad, "real world" population of chronic pain patients assessing both pain control with AVINZA as well as the potential risk for misuse and abuse.
Primary Outcome
Average pain intensity over last 24 hours rated by the subject using an 11 point numeric rating scale (ranging from 0=no pain to 10=worst pain) at Visit 3
Interventions
- DRUG morphine sulfate extended release capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,570 participants |
| Start Date | 2008-03 |
| Est. Completion | 2008-12 |
| Phase | Phase 4 |
What the finished NCT00640042 record still lists
NCT00640042 is an interventional study that assigns participants to a tested intervention. Its 1,570 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (203% higher).
The record links to 0 conditions, and to 1 intervention - of which morphine sulfate extended release capsules is the first listed.
NCT00640042 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00640042 about?
NCT00640042 is a clinical study titled "Evaluation of Risk Minimization, Assessment and Outcomes in Patients With Chronic Pain Taking Avinza". The purpose of this study is to provide information in a broad, "real world" population of chronic pain patients assessing both pain control with AVINZA as well as the potential risk for misuse and abuse.
What is the current status of trial NCT00640042?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,570 participants. The study started on 2008-03. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00640042?
The interventions under investigation include: morphine sulfate extended release capsules (DRUG).
Who is sponsoring clinical trial NCT00640042?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00640042's enrollment target sits among peer trials
1,570 50th of 2000 higher than 1,951 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06445946 · 1,572 participants · Phase 4
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
- NCT06034080 · 1,566 participants · NA
Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections
- NCT05483855 · 1,580 participants
Telehealth-delivered HealthcaRe to ImproVe Care
- NCT06881069 · 1,560 participants · NA
Reach Through Equitable Implementation in Utah
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia